RxDoctor Payments Data

Francisco Schwartz-Fernandes, MD

Surgery of the Hand · Ocala, FLNPI 1821244500

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (46.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Skeletal Dynamics Inc at 39.7% of the total. Reporting peaked in 2024 at $10,276 and has fallen 93.5% since, to $669 in 2025.

$25,834in general payments, 2019–2025

Across 115 payments — averaging $224.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Skeletal Dynamics Inc$10K
  • Axogen$4K
  • Arthrex$3K
  • Arthrosurface Incorporated$3K
  • CGG Medical Inc$1K
  • Anika Therapeutics, Inc.$1K
  • plus $4K from 18 others

What the payments were for

  • Consulting fees$3501%
  • Speaking & faculty fees$2,3009%
  • Travel & lodging$4,77218%
  • Food & beverage$6,41225%
  • Education$12,00046%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,834 in reported general payments places this provider in the 85th percentile of 60 surgery of the hand providers in Florida.

See all surgery of the hand providers in Florida

Medicare billing

Part B allowed, 2024
$126,915
Medicare patients
309
Services billed
1,137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin147$641
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen99$513
Methylprednisolone26$210
Ibuprofen33$81
Meloxicam23$62
Tramadol Hcl14$29

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Ocala

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →